
This review provides a comprehensive description of the pioneering development of discrete particle models and simulations conducted by the authors. They have been engaged in the discrete particle modeling of gas–solid two-phase flows with particle-particle collisions and the development of DEM–CFD models for the numerical analysis of both dense gas–solid two-phase flows and gas–liquid–solid three-phase flows. This review serves as a valuable resource for future developments in discrete particle modeling and simulation methods, including DEM–CFD modeling and simulation.

Powder products often consist of very fine particles, which therefore flow poorly and cause handling problems. Dry powder coating is an increasingly common approach to overcoming this problem, which works by fixing typically nano-sized particles to the host particle surfaces, thereby creating a spacing effect and reducing van der Waals interactions to improve flowability. This review outlines the theory behind dry powder coating and provides an overview of mixing mechanisms and techniques, methods to quantify the coating extent and coated product performance, and insights from modeling, including recently developed regime maps.

Nanoparticle technology (NPT), an advanced branch of particle technology, has rapidly progressed in Thailand over the past two decades. This review surveys Thailand's NPT contributions from 2008 to 2024, highlighting key research advances, industrial applications, and institutional support from the CEPT at Chulalongkorn University and NANOTEC under the NSTDA. Major topics include nanoparticle synthesis, characterization, and applications in health, well-being, and carbon capture and utilization. Addressing challenges related to aging society and carbon neutrality goals, the review emphasizes international collaboration, green nanotechnology, and global competitiveness to support Thailand's sustainable development.

Success in pulmonary disease treatment for inhaled products depends on solid-state chemistry, the nature of the drug particles, and their relationship to other particles in the formulation Comprehensive characterization of their physicochemical properties and aerosol performance ensures the quality of particulate products produced by a range of methods and having different properties, thereby assuring safety and efficacy. The delivered dose and aerodynamic particle size distribution are key characteristics related to lung exposure required in clinical trials for non-communicable, genetic, environmental, and communicable (i.e., infectious) diseases. New opportunities in inhaled biologicals are anticipated to drive future developments.